The Clinical Landscape of NRAS- mutated Juvenile Myelomonocytic Leukemia-like Myeloproliferation Includes Children With Costello Syndrome

J Pediatr Hematol Oncol. 2023 Apr 1;45(3):e401-e405. doi: 10.1097/MPH.0000000000002492. Epub 2022 Jun 3.

Abstract

Juvenile myelomonocytic leukemia (JMML) is a rare, aggressive pediatric disorder characterized by pathologic myeloproliferation because of alterations in RAS pathway genes. NRAS -mutated JMML encompasses a broad range of clinical severity. Herein we describe 4 unique cases of NRAS -mutated JMML and JMML-like myeloproliferation, 2 with somatic mutations and 2 with germline mutations. These cases illustrate the diverse clinical and hematologic presentation of this subtype of JMML, including a very unusual example presenting with Auer rods. Lastly, this is the first report of patients with phenotypic Costello syndrome presenting with JMML-like myeloproliferation, highlighting an important clinical phenomenon that has not been previously described.

MeSH terms

  • Child
  • Costello Syndrome*
  • GTP Phosphohydrolases / genetics
  • Germ-Line Mutation
  • Humans
  • Leukemia, Myelomonocytic, Juvenile* / genetics
  • Leukemia, Myelomonocytic, Juvenile* / pathology
  • Leukemia, Myelomonocytic, Juvenile* / therapy
  • Membrane Proteins / genetics
  • Mutation

Substances

  • NRAS protein, human
  • Membrane Proteins
  • GTP Phosphohydrolases